Point72 Asia (Singapore) Pte. Ltd. Allovir, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $379 Billion
- Q4 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Allovir, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 26,887 shares of ALVR stock, worth $263,492. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,887
Previous 30,261
11.15%
Holding current value
$263,492
Previous $24.5 Million
53.84%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ALVR
# of Institutions
49Shares Held
21.1MCall Options Held
41KPut Options Held
100-
Siren, L.L.C. New York, NY6.6MShares$64.7 Million0.12% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.03MShares$29.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.65MShares$25.9 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA1.91MShares$18.7 Million0.06% of portfolio
-
Jacobs Levy Equity Management, Inc Florham Park, NJ664KShares$6.51 Million0.0% of portfolio
About Allovir, Inc.
- Ticker ALVR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,063,400
- Market Cap $912M
- Description
- Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...